Robinson Value Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,306
Closed -$1.29M 109
2021
Q2
$1.29M Sell
5,306
-18
-0.3% -$4.43K 1.05% 36
2021
Q1
$1.32M Sell
5,324
-277
-5% -$66.1K 1.09% 35
2020
Q4
$1.29M Buy
+5,601
New +$1.29M 1.23% 34
2019
Q4
$2.74M Buy
+11,373
New +$2.51M 2.62% 14
2019
Q2
$2.23M Buy
+12,117
New +$2.17M 2.13% 17
2018
Q3
$2.74M Sell
13,210
-433
-3% -$85.3K 2.53% 12
2018
Q2
$2.52M Sell
13,643
-408
-3% -$72.2K 2.29% 15
2018
Q1
$2.4M Buy
14,051
+10,051
+251% +$1.85M 2.21% 17
2017
Q4
$696K Hold
4,000
0.61% 46
2017
Q3
$746K Hold
4,000
0.68% 42
2017
Q2
$689K Hold
4,000
0.64% 45
2017
Q1
$656K Sell
4,000
-1,150
-22% -$191K 0.61% 49
2016
Q4
$753K Buy
+5,150
New +$775K 0.71% 49

Other funds holding AMGN

Robinson Value Management's AMGN Position: Q3 2021 in Review

Robinson Value Management sold out of Amgen (AMGN) in Q3 2021, closing a stake of 5,306 shares — an estimated $1.29M sold.

Robinson Value Management first reported a position in AMGN in Q4 2016 and held it in 13 quarters. The position peaked at $2.74M in Q4 2019. 2,131 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.

  • Robinson Value Management reported no remaining Amgen position as of Q3 2021 after selling out during the quarter.
  • Robinson Value Management sold 5,306 Amgen shares in Q3 2021, an estimated $1.29M.
  • Robinson Value Management first reported a position in Amgen in Q4 2016 and held it in 13 quarters.
  • Robinson Value Management's Amgen position peaked at $2.74M in Q4 2019.
  • 2,131 funds tracked by Wall St. Rank held Amgen as of Q3 2021.

Based on Robinson Value Management's 13F filing for Q3 2021, filed 15 Nov 2021.